EirGenix Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares EirGenix Inc with three other
companies in this sector in TAIWAN :
Mycenax Biotech Incorporated
sales of 665.34 million Taiwanese Dollars [US$24.06 million]
of which 68%
was Technical Service Income),
Syn-Tech Chem. & Pharm. Co., Ltd.
(983.79 million Taiwanese Dollars [US$35.57 million]
of which 100%
was Sales revenue), and
(806.58 million Taiwanese Dollars [US$29.17 million]
During the first
quarter of 2021, sales at EirGenix Inc totalled
244.79 million Taiwanese Dollars .
an increase of 5.6%
from the 231.71 million Taiwanese Dollars in sales at the company during the first quarter of 2020.
During the previous 9 quarters, sales at EirGenix Inc have increased compared with the same quarter in the previous year.
EirGenix Inc reported sales of 1.07 billion Taiwanese Dollars (US$38.76 million)
December of 2020.
increase of 125.1%
versus 2019, when the company's sales were 476.09 million Taiwanese Dollars .